Premium Nahrungsergänzungsmittel | artgerecht

ANA Antibodies – Definition, Test & Significance

ANA antibodies (antinuclear antibodies) are immune proteins that target components of the cell nucleus and may indicate autoimmune diseases.

Regular tips about health Regular tips about health

Things worth knowing about "ANA antibodies"

ANA antibodies (antinuclear antibodies) are immune proteins that target components of the cell nucleus and may indicate autoimmune diseases.

What Are ANA Antibodies?

ANA antibodies (antinuclear antibodies) are proteins produced by the immune system that mistakenly target structures within the nucleus of the body's own cells. Under normal circumstances, the immune system only attacks foreign substances such as bacteria or viruses. However, in cases of immune dysregulation, the body may begin producing antibodies against its own tissues – known as autoantibodies. ANA antibodies belong to this group and serve as an important laboratory marker in the diagnosis of autoimmune diseases.

Causes and Occurrence

ANA antibodies can be detected in a wide range of diseases, but may also appear at low levels in healthy individuals. Common causes of a positive ANA result include:

Systemic lupus erythematosus (SLE): Detectable in over 95% of affected individuals
Sjogren syndrome: An autoimmune disease affecting the glands
Systemic sclerosis (scleroderma): A connective tissue disease
Polymyositis and dermatomyositis: Inflammatory muscle diseases
Mixed connective tissue disease (MCTD): An overlap syndrome of various autoimmune conditions
Rheumatoid arthritis: Inflammatory joint disease
Certain medications (drug-induced lupus)
Viral and bacterial infections
Liver diseases such as primary biliary cholangitis

In healthy older adults, ANA antibodies may appear at low titers without clinical significance.

Symptoms in Autoimmune Diseases Associated with ANA

A positive ANA result alone does not cause symptoms. However, the underlying autoimmune disease can trigger a variety of complaints, including:

Chronic fatigue and exhaustion
Joint and muscle pain
Skin changes (e.g., butterfly rash in SLE)
Dryness of the eyes and mouth (Sjogren syndrome)
Light sensitivity (photosensitivity)
Kidney, lung, or heart involvement in severe cases
General signs of inflammation such as fever

Diagnosis: The ANA Test

The ANA test is a blood test that examines a patient's serum for the presence of antinuclear antibodies. It is typically performed using indirect immunofluorescence (IIF) on human epithelial cells (HEp-2 cells).

Titers and Interpretation

Results are reported as a titer, meaning the dilution ratio of the blood serum (e.g., 1:80, 1:160, 1:320). A titer of 1:80 or higher is generally considered noteworthy. The higher the titer, the more likely a clinically relevant autoimmune disease is present – although a high titer alone is not conclusive.

Fluorescence Patterns

In addition to the titer, the fluorescence pattern provides important clues about the type of autoimmune disease:

Homogeneous pattern: Commonly seen in SLE (associated with anti-dsDNA and anti-histone antibodies)
Speckled pattern: Found in Sjogren syndrome, scleroderma, and MCTD
Nucleolar pattern: Typical for scleroderma
Centromere pattern: Characteristic of limited scleroderma (CREST syndrome)

Further Testing

A positive ANA result often leads to additional, more specific antibody tests, such as:

Anti-dsDNA antibodies: Highly specific for SLE
Anti-Sm antibodies: Also specific for SLE
Anti-SSA/Ro and Anti-SSB/La: Typical for Sjogren syndrome
Anti-Scl-70: Characteristic of diffuse scleroderma
Anti-Jo-1: Indicative of polymyositis/dermatomyositis

Treatment

A positive ANA result itself is not treated. Therapy is directed at the diagnosed underlying condition. Depending on the disease, the following treatment approaches may be considered:

Immunosuppressants (e.g., hydroxychloroquine, azathioprine, methotrexate) to suppress the overactive immune response
Corticosteroids during acute flares to reduce inflammation
Biologics (e.g., belimumab for SLE) as a more modern treatment option
Symptomatic therapy to relieve pain and discomfort

Regular monitoring of antibody titers is important to track disease activity over time.

References

Tan, E.M. et al. - The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism, 1982.
Agmon-Levin, N. et al. - International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Annals of the Rheumatic Diseases, 2014.
Meroni, P.L. & Schur, P.H. - ANA screening: an old test with new recommendations. Annals of the Rheumatic Diseases, 2010.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.